Flexible selection of a single treatment incorporating short-term endpoint information in a phase II/III clinical trial

scientific article

Flexible selection of a single treatment incorporating short-term endpoint information in a phase II/III clinical trial is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/SIM.6567
P932PMC publication ID4745001
P698PubMed publication ID26112909

P50authorNigel StallardQ43132046
Nick ParsonsQ53112989
Cornelia U KunzQ55473027
Tim FriedeQ58452336
P2093author name stringSusan Todd
P2860cites workGalantamine for Alzheimer's disease and mild cognitive impairmentQ24244773
Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modificationsQ28652785
Testing and estimation in flexible group sequential designs with adaptive treatment selectionQ36327917
Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: general conceptsQ36593604
Maximum inflation of the type 1 error rate when sample size and allocation rate are adapted in a pre-planned interim look.Q40344979
Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer's diseaseQ43747318
Type I error rate control in adaptive designs for confirmatory clinical trials with treatment selection at interimQ44216598
Sequential designs for phase III clinical trials incorporating treatment selectionQ44315582
A confirmatory seamless phase II/III clinical trial design incorporating short-term endpoint informationQ45374094
Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncologyQ46054107
A conditional error function approach for subgroup selection in adaptive clinical trialsQ46406244
Adaptive sample size calculations in group sequential trialsQ47213254
Modification of sample size in group sequential clinical trialsQ47213272
Designing a seamless phase II/III clinical trial using early outcomes for treatment selection: an application in multiple sclerosisQ48152166
When is a seamless study desirable? Case studies from different pharmaceutical sponsorsQ50116411
Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: opportunities and limitations.Q51933435
Evaluation of experiments with adaptive interim analyses.Q52364596
Monitoring pairwise comparisons in multi-armed clinical trials.Q52376256
Adaptive Dunnett tests for treatment selectionQ57305793
Recursive Combination TestsQ57305829
Flexible sequential designs for multi-arm clinical trialsQ57430497
A Comparison of Methods for Adaptive Treatment SelectionQ57430665
A group-sequential design for clinical trials with treatment selectionQ57430672
Designed extension of studies based on conditional powerQ70971455
Adaptive group sequential designs for clinical trials: combining the advantages of adaptive and of classical group sequential approachesQ74497643
Monitoring clinical trials with multiple armsQ74497647
Are flexible designs sound?Q80290439
P433issue23
P407language of work or nameEnglishQ1860
P921main subjectphase II clinical trialQ42824440
phase III clinical trialQ42824827
P304page(s)3104-3115
P577publication date2015-06-26
P1433published inStatistics in MedicineQ7604438
P1476titleFlexible selection of a single treatment incorporating short-term endpoint information in a phase II/III clinical trial
P478volume34

Search more.